HK1050027B - Progenitor cell preservation factors and related methods and products - Google Patents

Progenitor cell preservation factors and related methods and products Download PDF

Info

Publication number
HK1050027B
HK1050027B HK03102128.8A HK03102128A HK1050027B HK 1050027 B HK1050027 B HK 1050027B HK 03102128 A HK03102128 A HK 03102128A HK 1050027 B HK1050027 B HK 1050027B
Authority
HK
Hong Kong
Prior art keywords
fril
cells
days
cell
family member
Prior art date
Application number
HK03102128.8A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1050027A1 (en
Inventor
M. Gabriella Colucci
Maarten J. Chrispeels
Jeffrey G. Moore
Original Assignee
The Regents Of The University Of California
Imclone Systems Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California, Imclone Systems Incorporated filed Critical The Regents Of The University Of California
Publication of HK1050027A1 publication Critical patent/HK1050027A1/en
Publication of HK1050027B publication Critical patent/HK1050027B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK03102128.8A 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products HK1050027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/031307 WO2001049851A1 (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Publications (2)

Publication Number Publication Date
HK1050027A1 HK1050027A1 (en) 2003-06-06
HK1050027B true HK1050027B (en) 2006-04-13

Family

ID=22274423

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102128.8A HK1050027B (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Country Status (10)

Country Link
EP (1) EP1246919B1 (enExample)
JP (1) JP2003521900A (enExample)
CN (1) CN1406280A (enExample)
AT (1) ATE302848T1 (enExample)
AU (1) AU784361C (enExample)
CA (1) CA2395625A1 (enExample)
DE (1) DE69926920T2 (enExample)
ES (1) ES2249058T3 (enExample)
HK (1) HK1050027B (enExample)
WO (1) WO2001049851A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
EP2236156A3 (en) 2001-01-09 2011-01-05 Baylor Research Institute Methods for treating and diagnosing Psoriasis
JP2004527495A (ja) * 2001-02-27 2004-09-09 ファイロジックス・エルエルシー 組織および細胞を損傷から保護するための、そして損傷した組織を修復するための、組成物および方法
WO2005046613A2 (en) * 2003-11-12 2005-05-26 Morningside Venture Investments Limited Methods and compositions for the treatment of b cell lymphomas and other cancers
EP1901766A2 (en) * 2005-04-08 2008-03-26 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
JP2010516239A (ja) 2007-01-18 2010-05-20 スオメン プナイネン リスティ，ヴェリパルベル 細胞の産生に対する新規方法および試薬
CA2691787A1 (en) 2007-06-29 2009-01-08 The Trustees Of The University Of Pennsylvania Soft gel systems in modulating stem cell development
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
JP6247472B2 (ja) * 2013-08-06 2017-12-13 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
CN114262683B (zh) * 2022-03-01 2022-06-17 中国科学院动物研究所 一种表达vegfr3 d2多肽的细菌制剂及其构建方法和应用
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
US6310195B1 (en) * 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Also Published As

Publication number Publication date
EP1246919A1 (en) 2002-10-09
WO2001049851A1 (en) 2001-07-12
ES2249058T3 (es) 2006-03-16
EP1246919B1 (en) 2005-08-24
AU784361B2 (en) 2006-03-16
DE69926920T2 (de) 2006-06-29
JP2003521900A (ja) 2003-07-22
HK1050027A1 (en) 2003-06-06
AU2401400A (en) 2001-07-16
DE69926920D1 (de) 2005-09-29
AU784361C (en) 2007-03-15
CN1406280A (zh) 2003-03-26
CA2395625A1 (en) 2001-07-12
ATE302848T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
EP1246919B1 (en) Progenitor cell preservation factors and related methods and products
EP1017789B1 (en) Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6280724B1 (en) Composition and method for preserving progenitor cells
KR101493474B1 (ko) 조혈 줄기 세포를 증가시키고 이동시키는 방법들
JP2022088551A (ja) 増殖造血幹細胞／前駆細胞集団の利用
AU693032B2 (en) Methods for increasing hematopoietic cells
US6991794B1 (en) Progenitor cell preservation factors and methods for and products of their use
EP1584686A1 (en) Progenitor cell preservation factors and related methods and products
Selleri et al. Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders
KR20210065874A (ko) Il-2 단백질 및 cd80 단백질을 포함하는 융합단백질 및 nk 세포를 포함하는 항암 치료용 조성물
HK1084413A (en) Progenitor cell preservation factors and related methods and products
US20020132017A1 (en) Composition and method for preserving progenitor cells
CN114174328B (zh) Gaba激动剂和拮抗剂影响造血干细胞和巨核系祖细胞的分化
DE DK et al. NUKLEINSÄURE, WELCHE EINEN VON LEKTIN ABSTAMMENDEN FAKTOR ZUR PRÄSERVIERUNG VON PROGENITORZELLEN KODIERT ACIDE NUCLEIQUE CODANT UN FACTEUR DE CONSERVATION DE CELLULES PROGENITRICES DERIVE DE LA LECTINE
EP3292869A1 (en) Kal1 protein controlling cell cycle of hematopoietic stem cell, and use thereof
Sharkis STEM CELL PLASTICITY: WILL IT BE USEFUL TO REPAIR INJURY?
MXPA97009244A (en) Methods to increase hematopoyeti cells
CA2582216A1 (en) Method for ex-vivo purging in autologous transplantation
Sawadogo et al. Characterization of peripheral blood steady-state progenitor cells preserved in liquid culture conditions with or without GM-CSF and IL2
Cohen-Solal et al. Mpl-Ligand and the Regulation of Megakaryocytopoiesis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091230